Press-release for stocks in the finance and insurance sector

therapeutics sector : Finance and insurance

save search

Silo Pharma set to Acquire Exclusive Licensing for Promising Alzheimer’s Disease Therapeutic
Published: 2024-04-10 (Crawled : 12:00) - globenewswire.com
SILO | $1.99 0.71% -0.82% 59K

Finance and Insurance

| -7.01% | O: 1.87% H: 4.59% C: -3.67%
pharma disease alzheimer’s acquire spc-14

Silo Pharma Exercises Option for Exclusive License Agreement for First-in-Class PTSD and Stress-Induced Anxiety Therapeutic
Published: 2024-03-20 (Crawled : 12:30) - globenewswire.com
SILO | $1.99 0.71% -0.82% 59K

Finance and Insurance

| 13.71% | O: 1.14% H: 2.26% C: 2.26%
pharma license agreement

Silo Pharma Files Patent for Groundbreaking Ketamine Implant Therapeutic to Target Fibromyalgia and Chronic Pain
Published: 2024-03-18 (Crawled : 12:00) - globenewswire.com
SILO | $1.99 0.71% -0.82% 59K

Finance and Insurance

| 8.15% | O: -6.52% H: 9.88% C: 4.07%
ketamine pharma patent fibromyalgia implant

Silo Pharma Completes Successful Dose-Ranging Study of SPC-15 Intranasal Therapeutic for PTSD
Published: 2024-02-28 (Crawled : 13:30) - globenewswire.com
SILO | $1.99 0.71% -0.82% 59K

Finance and Insurance

| 28.39% | O: 10.32% H: 3.51% C: -5.26%
spc-15 pharma study spc-14

Vico Therapeutics Announces $60 million (€54 million) Series B Financing to Advance VO659 Clinical-Stage Program for Rare Neurological Diseases and Expand Pipeline
Published: 2024-01-05 (Crawled : 07:00) - prnewswire.com
BNPQF | News | $70.45 2.76% -13.4% 910

Finance

| 2.1% | O: 0.0% H: 0.0% C: -0.2%
BNPQY | News | $35.58 2.1% -2.68% 97K

Finance and Insurance

| 3.58% | O: -0.03% H: 1.19% C: 0.64%
vo659 rare million pipeline series neurological program therapeutics

AstriVax Awarded €3 Million Grant to Advance therapeutic Hepatitis B Vaccine
Published: 2023-12-12 (Crawled : 07:00) - biospace.com/
BNPQY | News | $35.58 2.1% -2.68% 97K

Finance and Insurance

| 8.11% | O: -0.3% H: 0.12% C: 0.03%
hepatitis vaccine grant

Silo Pharma to Initiate Dose-Ranging Study of Novel Intranasal Therapeutic SPC-15 for the Treatment of PTSD
Published: 2023-11-08 (Crawled : 13:00) - globenewswire.com
SILO | $1.99 0.71% -0.82% 59K

Finance and Insurance

| 29.22% | O: -0.65% H: 5.23% C: 1.31%
spc-15 pharma treatment study spc-14

Poseida Therapeutics to Join Russell 3000® and Russell 2000® Indexes
Published: 2023-06-26 (Crawled : 14:00) - biospace.com/
LDNXF | $115.907 4.5% -12.32% 870

Finance

| 7.82% | O: 0.38% H: 0.0% C: -0.84%
LNSTY | $28.6 1.31% 0.53% 130K

Finance and Insurance

| 6.56% | O: 0.45% H: 0.07% C: -0.22%
PSTX | $2.155 6.68% 6.48% 550K

Health Technology

| -8.51% | O: -0.43% H: 0.0% C: -10.68%
3000 therapeutics

Carisma Therapeutics to be Added to Russell 2000®, Russell 3000® and Russell Microcap® Indexes
Published: 2023-06-26 (Crawled : 13:20) - biospace.com/
LDNXF | $115.907 4.5% -12.32% 870

Finance

| 7.82% | O: 0.38% H: 0.0% C: -0.84%
LNSTY | $28.6 1.31% 0.53% 130K

Finance and Insurance

| 6.56% | O: 0.45% H: 0.07% C: -0.22%
2000 therapeutics

AVITA Medical Rejoins the Russell 3000 Index
Published: 2023-06-26 (Crawled : 12:00) - globenewswire.com
LDNXF | $115.907 4.5% -12.32% 870

Finance

| 7.82% | O: 0.38% H: 0.0% C: -0.84%
LNSTY | $28.6 1.31% 0.53% 130K

Finance and Insurance

| 6.56% | O: 0.45% H: 0.07% C: -0.22%
RCEL | $8.55 -1.04% -0.82% 560K

Health Technology

| -47.22% | O: -1.73% H: 0.25% C: -1.32%
index 3000 medical

Cidara Therapeutics Added to Russell Microcap® Index
Published: 2023-06-26 (Crawled : 12:00) - globenewswire.com
LDNXF | $115.907 4.5% -12.32% 870

Finance

| 7.82% | O: 0.38% H: 0.0% C: -0.84%
LNSTY | $28.6 1.31% 0.53% 130K

Finance and Insurance

| 6.56% | O: 0.45% H: 0.07% C: -0.22%
CDTX | News | $0.5139 -24.54% -32.62% 3.7M

Health Technology

| -56.03% | O: 0.86% H: 0.0% C: -5.13%
microcap index therapeutics

Larimar Therapeutics Set to Join Russell 3000® Index
Published: 2023-06-21 (Crawled : 20:00) - globenewswire.com
LDNXF | $115.907 4.5% -12.32% 870

Finance

| 5.61% | O: -0.26% H: 0.0% C: -0.89%
LNSTY | $28.6 1.31% 0.53% 130K

Finance and Insurance

| 3.66% | O: -0.87% H: 0.0% C: -1.32%
LRMR | $6.4 -1.99% -1.87% 240K

Health Technology

| 84.44% | O: 1.44% H: 0.28% C: -4.55%
3000 index set therapeutics

Zevra Therapeutics to be Added to Russell 2000® and Russell 3000® Indexes Effective June 26, 2023
Published: 2023-06-20 (Crawled : 12:00) - globenewswire.com
ZVRA | $4.57 1.11% 1.09% 110K

n/a

| -21.34% | O: 1.55% H: 6.1% C: 5.25%
LDNXF | $115.907 4.5% -12.32% 870

Finance

| 3.03% | O: -0.3% H: 0.0% C: -1.26%
LNSTY | $28.6 1.31% 0.53% 130K

Finance and Insurance

| 0.99% | O: -1.45% H: 0.87% C: 0.18%
2000 therapeutics

4 Singapore REITs That Undertook Acquisitions to Boost Their DPUs – The Smart Investor
Published: 2023-06-13 (Crawled : 00:00) - spacfeed.com
CFFS | $10.84 -0.27% 200

n/a

| 4.5% | O: -0.19% H: 0.77% C: 0.0%
FATP | $10.915 -0.14% 8.2K

n/a

| 1.48% | O: -0.56% H: 0.28% C: 0.09%
CZFS 4 | $44.5 -1.11% -1.79% 2.6K

Finance and Insurance

| -47.83% | O: 0.0% H: 2.52% C: 0.94%
QLGN | $0.2953 -7.14% -8.16% 47K

Health Technology

| -70.3% | O: -1.5% H: 3.54% C: -1.5%
acquisitions smart

Silo Pharma Signs Agreement to Develop First-in-Class Ketamine Implant Therapeutic
Published: 2023-06-13 (Crawled : 12:00) - globenewswire.com
SILO | $1.99 0.71% -0.82% 59K

Finance and Insurance

| -16.03% | O: 13.08% H: 6.72% C: -16.04%
ketamine pharma implant agreement

Kineta Set to Join Russell Microcap® Index
Published: 2023-05-24 (Crawled : 11:00) - globenewswire.com
KA A | $0.6349 20.47% 15.01% 820K

Manufacturing

| -79.14% | O: -0.33% H: 3.32% C: 2.33%
LDNXF | $115.907 4.5% -12.32% 870

Finance

| 10.48% | O: -1.08% H: 0.0% C: -0.56%
LNSTY | $28.6 1.31% 0.53% 130K

Finance and Insurance

| 7.92% | O: -1.22% H: 0.0% C: -0.87%
microcap index set

Lineage Cell Therapeutics Expected to Be Added to Russell 3000® Index
Published: 2023-05-22 (Crawled : 13:20) - biospace.com/
LDNXF | $115.907 4.5% -12.32% 870

Finance